Search for Clinical Trial Results

Hereditary Leiomyomatosis and Renal Cell Cancer - 3 Studies Found
Status | Study |
Recruiting |
Study Name: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Condition:
Date: 2010-05-25 Interventions:
|
Completed |
Study Name: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin Condition:
|
Recruiting |
Study Name: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma Condition:
|